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Department of Healthcare Associated Infection and Antimicrobial Resistance, Public Health England, London, UKAbstractWe sought to assess the impact of body mass index on the risk of surgical site infection in a prospective cohort study of 206 National Health
Service (NHS) hospitals in England between 2007 and 2011. Body mass index was available for 159 720 of 350 089 operations among patients
undergoing abdominal hysterectomy, coronary artery bypass graft, hip replacement, knee replacement, or large-bowel surgery. Among these
patients, the risk of surgical site infection ranged from 0.65% for knee replacement to 11.04% for large-bowel surgery. Overall, 127 512
(79.8%) patients were overweight or obese (body mass index of 25 kg/m2). Obesity was associated with a 1.1-fold to 4.4-fold increase
in the adjusted odds of developing surgical site infection as compared with normal weight, depending on the type of surgery. The
population-attributable fraction (PAF) for body mass index was greatest in overweight (body mass index of 25.0–29.9 kg/m2) patients
undergoing coronary artery bypass graft, accounting for 15% of their overall risk of surgical site infection (PAF 0.15; 95% CI 0.09–0.22).
Being overweight or obese substantially increased the likelihood of patients developing surgical site infection. Given the increasingly high
proportion of the surgical population who are overweight, this is likely to place a considerable additional burden on the NHS. Strategies
for mitigating this excess risk need to be found.
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E-mail: simon.thelwall@phe.gov.ukIntroductionInfections of surgical wounds can have serious consequences,
both for the patient and for the care facility: surgical site
infection (SSI) increases the length of postoperative stay, patient
mortality, and the need for re-operation [1]. Revision of
infected total hip replacement has been estimated to cost an
average of V32 000 [2]. Once the acute infection is resolved,
the patient’s mobility may be impaired, further reducing qualityMicrobiol Infect 2015; 21: 1008.e1–1008.e8
own Copyright © 2015 Clinical Microbiology and Infection published by Elsevier Ltd on behal
p://dx.doi.org/10.1016/j.cmi.2015.07.003of life [3]. The most recent estimate suggests that 15.7% of
hospital-acquired infections are SSIs, making SSI the third most
prevalent form of healthcare-associated infection [4].
Global trends in obesity are showing a consistent increase,
with the age-standardized mean global body mass index (BMI)
increasing by 0.4 kg/m2 to 0.5 kg/m2 per decade between 1980
and 2008 [5]. In England, the prevalence of obesity or being
overweight in adults has increased considerably in the past 7
years, from 52.9% of the population in 1993 to 62.8% in 2010
[6]. The concomitant impact on population health is projected
to inﬂate the cost of providing healthcare by £1.9–2 billion per
year in the UK and by $48–66 billion per year in the USA by
2030 [7]. Obesity has a wide range of consequences, increasing
the risk of type 2 diabetes, coronary heart disease, and oste-
oarthritis [8]. To this list we can add an increase in the risk of
infection [9].f of European Society of Clinical Microbiology and Infectious Diseases. All rights reserved
CMI Thelwall et al. Impact of obesity on risk of postoperative infection 1008.e2Given the increasing prevalence of obesity, we sought to
determine the additional risk of developing SSI attributable to
being overweight or obese in England. We analysed data sub-
mitted by participating hospitals to the national Surgical Site
Infection Surveillance Service in England.Materials and methodsPublic Health England provides an infrastructure facilitating hos-
pital surveillance of SSI in England. Since 2004, all National Health
Service (NHS) Hospitals in England that perform orthopaedic
surgery have been required to submit data on operations con-
ducted in three consecutive months in at least one of four or-
thopaedic categories within a ﬁnancial year to the Surgical Site
Infection Surveillance Service managed by Public Health England
[10]. Hospitals could choose from the following orthopaedic cat-
egories: hip replacement, knee replacement, repair of neck of fe-
mur, or reduction of long bone fracture. The Surgical Site Infection
Surveillance Service offers surveillance for an additional 13
categories of surgery inwhich hospitalsmay opt to participate [10].
The study cohort was composed of patients undergoing
surgery in one of ﬁve categories of surveillance (hip replacement,
knee replacement, coronary artery bypass graft, large bowel
surgery, and abdominal hysterectomy) in NHS hospitals in En-
gland between 1 January 2007 and 31 December 2011. Surgical
categories for inclusion in the study were selected on the basis of
having >25% completion for height and weight ﬁelds and >20
participating hospitals in the past 5 years. All patients undergoing
procedures included in a predeﬁned list of Ofﬁce of Population
Censuses and Surveys surgical operations [11] were included in
the study. Because of the low risk of infection, patients under-
going surgery performed solely laparoscopically were not
included in the SSI surveillance, and were therefore not available
for inclusion in the cohort.
Case ascertainment
All patients were prospectively monitored by hospital surveil-
lance staff for SSI for a minimum of 30 days. Patients receiving
permanent prosthetic implants were followed up for 1 year. Any
patients re-admitted to hospital for management of SSI during
the follow-up period were identiﬁed. To ensure consistency and
accuracy of data collection, hospital staff involved in the data
collection were required to attend training provided by Public
Health England. Further quality checks were performed by
Public Health England staff when data were submitted to them.
Case and clinical deﬁnitions
SSIs were broadly deﬁned according to internationally accepted
CDC criteria [12], with cases being deﬁned on the basis on anyCrown Copyright © 2015 Clinical Microbiology and Infection published by Elsevier Ltd on behalfof the following: purulent drainage from the incision, laboratory
conﬁrmation, radiological examination, spontaneous dehiscence
or surgical opening of a deep wound, or the presence of clinical
signs combined with a clinician’s diagnosis [10]. Infections were
classiﬁed as superﬁcial (those affecting only skin or subcutane-
ous tissue within 30 days of operation), deep (affecting fascial or
muscle tissues) or organ-space (any part of the body opened or
manipulated during surgery, excluding skin, muscle or fascial
tissue) by clinicians. The minor deviations from CDC deﬁni-
tions were that infections detected by swab also required the
presence of pus cells, and that superﬁcial infection deﬁned by
the clinician’s diagnosis also required the presence of two
clinical signs (heat, redness, swelling, or pain). BMI was deﬁned
as the patient’s weight in kilograms divided by the square of the
height in metres. Classiﬁcation of the BMI index followed in-
ternational guidelines: underweight (<18.5), normal weight
(18.5–24.99), overweight (25–29.99), obese I (30–34.99),
obese II (35–39.99), and obese III (>40) [13]. Patients aged <18
years were excluded from analysis, as BMI is not an appropriate
measure of obesity in children [14].
Data source, extraction, and analysis
Data for operations performed in NHS hospitals in England
between 1 January 2007 and 31 December 2011 were
extracted from Public Health England’s surgical site infection
surveillance database for analysis.
The core dataset required for each patient included the pa-
tient’s date of birth, surgical procedure, operation duration,
wound class, American Society of Anesthesiologists score, and
prosthetic implant insertion. Hospitals were also expected to
provide data on additional risk factors, including whether the
operationwas performed as an emergencyor as a result of trauma,
and whether multiple procedures through the same incision were
performed. Hospitals had the option to contribute data on patient
height and weight, and these data were used to calculate BMI.
All statistical analyses were performed in Stata version 12.
Differences in proportions were assessed with the χ2 test.
Differences in distribution for non-normally distributed data
(operation duration and patient age) were tested with the
Wilcoxon rank sum test. To adjust for the effect of factors
other than BMI on the risk of SSI, stepwise multivariable logistic
regression was performed, with adjustment for age, sex,
American Society of Anesthesiologists score, wound class,
duration of operation, whether surgery was due to trauma,
whether an implant was inserted, lead surgeon grade, and
whether multiple surgical procedures were performed through
the same incision. Interactions were tested with the χ2 test of
heterogeneity in Mantel–Haenszel stratiﬁcation. The outputs of
the multivariable regression models were used to calculate the
population-attributable fraction (PAF). The PAF represents theof European Society of Clinical Microbiology and Infectious Diseases. All rights reserved,
CMI, 21, 1008.e1–1008.e8
TABLE 2. Characteristics of patients undergoing surgery in
ﬁve surveillance categories in England (2007–2011)
Without BMI With BMI
1008.e3 Clinical Microbiology and Infection, Volume 21 Number 11, November 2015 CMIproportion of SSIs that would be avoided if all patients were of
normal weight, assuming a causal relationship between BMI and
the risk of SSI.Patient characteristic
No. of
operations %
No. of
operations %ResultsASA score >2 70 085 36.82 57 510 36.01a
Wound class contaminated or dirty 2966 1.56 1140 0.71a
Operation duration > T-timeb 28 934 15.20 19 560 12.25a
Prosthesis inserted 174 017 91.41 151 169 94.65a
Revisionc 16 771 9.98 10 377 7.70a
Male 80 128 42.84 72 070 45.73a
Trauma 4919 2.58 796 0.50a
Emergencyd 1016 4.55 401 1.61a
Multiple surgical proceduresd 8136 36.45 6263 25.18a
Antimicrobial prophylaxis 171 933 90.32 145 049 90.81a
Antibiotic cementc 106 222 63.21 84 931 62.98a
Median duration (IQR) 90 (69–118) 88 (67–120)
Median age in years (IQR) 70.1 (62.14–77.01) 69.85 (62.07–76.57)
ASA, American Society of Anesthesiologists; BMI, body mass index; IQR,
interquartile range.
ap <0.001.
b75th percentile of the duration of operation for given category of surgery.
cHip and knee replacement only.
dAbdominal hysterectomy, coronary artery bypass graft and large-bowel surgery
only.Between 1 January 2007 and 31 December 2011, 206 hospitals
submitted data on 350 089 operations, fromwhich 4832 inpatient
and re-admission SSIs were identiﬁed. The overall risk of SSI was
1.38%, ranging from 0.59% (929/156 598) for knee replacement
surgery to 10.34% (1522/14 716) for large-bowel surgery.
BMI data were available for 159 720 records (45.62%), with
completion varying by surgical category. Coronary artery
bypass graft patients had the highest proportion of records with
BMI data (18 580 of 27 014 records, 68.78%), whereas large-
bowel surgery patients had the lowest (4158 of 14 716 re-
cords, 28.25%; Table 1).
Of those patients for whom BMI data were available, 67 606
(42.33%) were classed as obese, 59 906 (37.51%) were over-
weight, 31 102 (19.47%) were of normal weight, and 1106
(0.69%) were underweight. For coronary artery bypass graft
patients, there was evidence of a substantial difference in the risk
of SSI between patients for whom BMI data were available and
patients for whom BMI data were not available (2.74% vs. 5.02%,
p <0.001). Smaller, statistically signiﬁcant differences similarly
existed for hip replacement patients (0.84% vs. 0.7%, p <0.01)
and knee replacement patients (0.54% vs. 0.65%, p <0.01). Dif-
ferences in patient characteristics between patients for whom
BMI was or was not reported are given in Table 2, and further
detailed by surgical category in Table S1. In a multivariable
analysis of variables associated with missing BMI data, hospital
identity had the strongest association (data not shown). After
adjustment for hospital identity, the presence of an SSI was not
was not associated with completion of BMI.TABLE 1. Distribution of surgical site infections by
surveillance category in England (2007–2011)
Surgical category
Without BMI With BMI
No. of
operations
No. (%)
of SSIs
No. of
operations
No. (%)
of SSIs
Abdominal hysterectomy 3331 46 (1.38) 2130 32 (1.50)a
Coronary artery bypass
graft
8434 231 (2.74) 18 580 932 (5.02)b
Hip replacement 83 624 699 (0.84) 62 676 441 (0.70)b
Knee replacement 84 422 457 (0.54) 72 176 472 (0.65)b
Large-bowel surgery 10 558 1063 (10.07) 4158 459 (11.04)b
Total 190 369 2496 (1.31) 159 720 2336 (1.46)b
BMI, body mass index; SSI, surgical site infection.
ap <0.05.
bp <0.001.
Crown Copyright © 2015 Clinical Microbiology and Infection published by Elsevier Ltd on behalf
CMI, 21, 1008.e1–1008.e8The risk of a patient developing an SSI increased with
increasing degree of obesity as compared with normal-weight
patients for all categories of surgery (Fig. 1). The relationship
between the degree of being overweight or obese and the in-
crease in risk of SSI varied by surgical category. For abdominal
hysterectomy, knee replacement and large-bowel surgery pa-
tients, the risk of SSI increased approximately linearly with
increasing BMI. For coronary artery bypass graft patients, the
increase in risk of SSI between obese I and obese II patients was
much greater than the increase between other sequential cat-
egories of BMI. Small differences in risk existed between
normal-weight patients and obese III patients for hip and knee
replacement (0.48% vs. 2.27% for hip replacement, and 0.43%
vs. 1.27% for knee replacement). Larger differences existed
between normal-weight patients and obese III patients under-
going abdominal hysterectomy and coronary artery bypass graft
(1.14% vs. 3.55% for abdominal hysterectomy, and 3.00% vs.
9.59% for coronary artery bypass graft). For large-bowel sur-
gery, 25.29% (95% CI 16.16–34.42) of obese III patients
developed SSI, and 7.53% (95% CI 6.18–8.88) of normal-weight
patients developed SSI.
Complete data were available for 139 901 procedures for
use in multivariable logistic regression. After adjustment for
clinical and demographic risk factors, the odds of developing SSI
were 1.28–1.66-fold greater in overweight patients than in
normal-weight patients (Table 3).
For obese I patients, the adjusted odds of SSI were 1.09–2.13-
fold higher, for obese II patients, the odds of SSI were 1.78–3.79-
fold higher, and for obese III patients, the odds of SSI were
2.71–4.40-fold higher. The low numbers of patients in the
abdominal hysterectomy category meant that the relationshipof European Society of Clinical Microbiology and Infectious Diseases. All rights reserved,
FIG. 1. Unadjusted risk of surgical site infection (SSI) by body mass index (BMI) and surgical category, England 2007–2011.
CMI Thelwall et al. Impact of obesity on risk of postoperative infection 1008.e4between increasing BMI and increasing odds of SSI was under-
powered, but the trend was towards a positive association.
Although obese III patients had the greatest increase in odds
of SSI, the greatest PAF was for overweight patients undergoing
coronary artery bypass graft surgery, with 15% of the infection
risk being attributable to being overweight (PAF 0.15; Table 3).
In contrast, being obese I accounted for 14% of SSIs occurring
among overweight patients (PAF 0.14), 9% among obese II
patients (PAF 0.09) and 3% among obese III patients (PAF 0.03)
undergoing coronary artery bypass graft surgery.
Obesity may lead to a greater duration of operation, so some
of the increased risk of SSI posed by obesity might be mediated
through the duration of operation. To investigate this, regression
analyses were repeated, excluding duration of operation.
Exclusion of operation duration from multivariable adjustments
did not substantially change the effect of BMI on the odds of SSI.
The distribution of organisms identiﬁed from surgical
wounds varied little by BMI category (Table 4). Enterococci
were identiﬁed from a greater proportion of SSIs among
overweight or obese patients undergoing coronary artery
bypass grafting than of SSIs among normal-weight or under-
weight patients (6.5% vs. 0%, p 0.018). Among coronary artery
bypass graft patients, other Gram-negative bacteria were more
frequently identiﬁed among underweight or normal-weight
patients than among overweight or obese patients (3.7% vs.
0.2%, p 0.001). Among hip replacement patients, members of
the Enterobacteriaceae were more frequently identiﬁed among
normal-weight patients than among overweight or obese pa-
tients (27.5% vs. 18.6%, p 0.048).DiscussionThe results of this large, multicentre, multi-category study
indicate that being overweight or obese signiﬁcantly increasedCrown Copyright © 2015 Clinical Microbiology and Infection published by Elsevier Ltd on behalfthe risk of postsurgical infection in a number of surgical cate-
gories. This increase in risk persisted after adjustment for other
risk factors, including the degree of wound contamination, the
preoperative physical status of the patient, and the duration of
the operation.
This study conﬁrms the ﬁndings of previous, smaller-scale
studies. A multicentre nested case–control study of 460 pa-
tients undergoing coronary artery bypass grafting in Australia
found an adjusted OR for SSI of 3.91 for obese II and obese III
patients [15]. In comparison, a single-centre cohort study of
591 patients undergoing surgery in a range of different spe-
cialties in the USA found an OR of 1.3 for obese patients [16].
Mechanism of effect
The mechanism by which obesity increases the risk of SSI is
likely to be multifactorial [17]. Obese surgical patients have
been shown to have reduced subcutaneous tissue oxygenation
and to require a greater fraction of inspired oxygen to achieve
the same arterial oxygen tension as normal-weight patients,
thus predisposing them to SSI [18]. Wound hypoxia impairs
healing by a number of potential mechanisms; healing wounds
have high metabolic demands, and insufﬁcient oxygen will slow
the healing process. Immune cells also have high oxygen de-
mands, requiring oxygen for the formation of microbicidal
reactive oxygen species [19].
In addition to poor tissue oxygenation, adequate tissue levels
of prophylactic antibiotics may be harder to achieve in obese
patients [20]. Antimicrobials show different pharmacokinetics
when administered to obese patients, with both hydrophilic and
hydrophobic compounds generally having a higher volume of
distribution, requiring a higher dose to reach the same plasma
drug concentrations as for non-obese patients [20]. Hepatic
clearance may also be increased in obese patients [21].
Therefore, obese patients may need to be dosed differently
from non-obese patients [22].of European Society of Clinical Microbiology and Infectious Diseases. All rights reserved,
CMI, 21, 1008.e1–1008.e8
T
A
B
L
E
3.
M
ul
ti
va
ri
ab
le
an
al
ys
is
o
f
ri
sk
fa
ct
o
rs
fo
r
su
rg
ic
al
si
te
in
fe
ct
io
n
in
ﬁ
ve
ca
te
go
ri
es
o
f
su
rv
ei
lla
nc
e
in
E
ng
la
nd
(2
00
7
–
20
11
)
B
M
I
ca
te
go
ry
A
bd
o
m
in
al
hy
st
er
ec
to
m
y
(n
[
16
01
)
C
o
ro
na
ry
ar
te
ry
by
pa
ss
gr
af
t
(n
[
15
13
8)
H
ip
re
pl
ac
em
en
t
(n
[
55
71
7)
K
ne
e
re
pl
ac
em
en
t
(n
[
63
95
0)
L
ar
ge
-b
o
w
el
su
rg
er
y
(n
[
34
95
)
O
R
(9
5%
C
I)
P
A
F
O
R
(9
5%
C
I)
P
A
F
O
R
(9
5%
C
I)
P
A
F
O
R
(9
5%
C
I)
P
A
F
O
R
(9
5%
C
I)
P
A
F
U
nd
er
w
ei
gh
t
—
—
1.
65
(0
.6
5
–
4.
19
)
0.
00
(0
.0
0
–
0.
01
)
1.
02
(0
.3
2
–
3.
26
)
0.
00
(−
0.
01
to
0.
01
)
1.
20
(0
.1
6
–
8.
81
)
0.
00
(0
.0
0
–
0.
01
)
0.
59
(0
.2
3
–
1.
52
)
—
N
or
m
al
w
ei
gh
t
1.
00
—
1.
00
—
1.
00
—
1.
00
—
1.
00
—
O
ve
rw
ei
gh
t
1.
32
(0
.3
7
–
4.
74
)
0.
07
(−
0.
3
to
0.
33
)
1.
66
(1
.3
2
–
2.
09
)a
0.
15
(0
.0
9
–
0.
22
)
1.
22
(0
.9
0
–
1.
66
)
0.
06
(−
0.
03
to
0.
14
)
1.
28
(0
.8
9
–
1.
86
)
0.
07
(−
0.
03
to
0.
15
)
1.
50
(1
.1
4
–
1.
97
)b
0.
12
(0
.0
3
–
0.
19
)
O
be
se
I
1.
09
(0
.2
4
–
4.
94
)
0.
01
(−
0.
22
to
0.
20
)
2.
13
(1
.6
7
–
2.
73
)a
0.
14
(0
.0
9
–
0.
18
)
1.
75
(1
.2
7
–
2.
40
)
0.
12
(0
.0
5
–
0.
18
)b
1.
59
(1
.0
9
–
2.
30
)b
0.
12
(0
.0
3
–
0.
20
)
2.
02
(1
.4
8
–
2.
76
)a
0.
10
(0
.0
5
–
0.
15
)
O
be
se
II
2.
70
(0
.6
4
–
11
.4
0)
0.
12
(−
0.
10
to
0.
29
)
3.
79
(2
.8
2
–
5.
08
)a
0.
09
(0
.0
7
–
0.
12
)
2.
30
(1
.5
8
–
3.
34
)
0.
08
(0
.0
4
–
0.
11
)a
1.
78
(1
.1
8
–
2.
69
)b
0.
07
(0
.0
2
–
0.
12
)
2.
99
(1
.9
0
–
4.
70
)a
0.
05
(0
.0
2
–
0.
07
)
O
be
se
III
3.
45
(0
.7
6
–
15
.6
4)
0.
13
(−
0.
07
to
0.
30
)
3.
67
(2
.4
1
–
5.
59
)a
0.
03
(0
.0
2
–
0.
05
)
4.
40
(2
.8
8
–
6.
70
)
0.
08
(0
.0
4
–
0.
10
)a
3.
20
(2
.0
6
–
4.
97
)a
0.
09
(0
.0
5
–
0.
12
)
2.
71
(1
.4
6
–
5.
01
)b
0.
02
(0
.0
1
–
0.
04
)
M
od
el
s
w
er
e
ad
ju
st
ed
fo
r
A
m
er
ic
an
So
ci
et
y
of
A
ne
st
he
si
ol
og
is
ts
(A
SA
)s
co
re
,w
ou
nd
cl
as
s,
du
ra
tio
n
of
op
er
at
io
n,
pa
tie
nt
ag
e,
pa
tie
nt
se
x,
tr
au
m
a,
w
he
th
er
su
rg
er
y
w
as
pe
rf
or
m
ed
as
an
em
er
ge
nc
y,
w
he
th
er
an
im
pl
an
tw
as
in
se
rt
ed
,s
ur
ge
on
gr
ad
e,
an
d
w
he
th
er
m
ul
tip
le
su
rg
ic
al
pr
oc
ed
ur
es
w
er
e
pe
rf
or
m
ed
th
ro
ug
h
th
e
sa
m
e
in
ci
si
on
.T
he
m
od
el
fo
r
ab
do
m
in
al
hy
st
er
ec
to
m
y
w
as
no
t
ad
ju
st
ed
fo
r
pa
tie
nt
se
x.
H
ip
re
pl
ac
em
en
t
an
d
kn
ee
re
pl
ac
em
en
t
m
od
el
s
w
er
e
no
t
ad
ju
st
ed
fo
r
em
er
ge
nc
y
st
at
us
,p
ro
st
he
tic
im
pl
an
t,
or
m
ul
tip
le
pr
oc
ed
ur
es
.
BM
I,
bo
dy
m
as
s
in
de
x;
PA
F,
po
pu
la
tio
n-
at
tr
ib
ut
ab
le
fr
ac
tio
n.
a p
<
0.
00
1.
b p
<
0.
05
.
1008.e5 Clinical Microbiology and Infection, Volume 21 Number 11, November 2015 CMI
Crown Copyright © 2015 Clinical Microbiology and Infection published by Elsevier Ltd on behalf
CMI, 21, 1008.e1–1008.e8Clinical implications
Trends in population health suggest that obesity is likely to become
a more signiﬁcant factor in predisposing to wound infection. In
2010, the proportionof adults in Englandwhowereoverweight or
obese was 62.8%; by 2020, the prevalence of overweight and
obesity among adults and children in England is expected to reach
70% [7]. National Joint Registry data show that, for primary hip
replacement, the proportion of patients with a BMI between 30
and 44 has increased from 69% to 77% [23]. The same report
shows an increase in the number of primary hip and primary knee
replacements being performed, a trend mirrored in many devel-
oped countries. In contrast, however, the number of patients
undergoing coronary artery bypass graft surgery has remained
approximately level since 1997 [24].
To determine the proportion of the infections attributable to
being overweight or obese, PAFs were calculated. We found
that, although the greatest OR was for obese III patients, the
greatest excess infection risk was contributed by being over-
weight rather than by being obese. This is because, among cases
in this study, the prevalence of being overweight is greater than
the prevalence of being obese III, resulting in a greater popu-
lation at risk. As the PAF is a function of both the prevalence of
the risk factor and the risk posed by the risk factor, the pro-
portion of infections attributable to being overweight and obese
will continue to increase if the current trends in obesity
continue.
Reducing the weight of prospective overweight surgical pa-
tients would perhaps reduce the numbers of patients requiring
surgery, and could reduce the number of infections in those
that go on to undergo surgery. The idea that 15% of SSIs could
be prevented by eliminating overweight in patients undergoing
coronary artery bypass graft surgery is appealing, but imprac-
tical. The degree to which obesity can be reduced prior to
surgery or the degree to which the effects of obesity can be
mitigated is not clear. A recent cohort study comparing patients
undergoing joint replacements 6 months before bariatric sur-
gery with patients undergoing joint replacements 6 months
after bariatric surgery failed to show a signiﬁcant difference in
the 30-day joint infection rate, suggesting that weight loss prior
to surgery may not improve SSI outcomes [25].
As short-term weight loss for the majority of these patients
is unlikely to be achievable preoperatively, other approaches
are needed to mitigate against the effects of obesity. One option
is the use of alternative antibiotic prophylaxis regimens. A
randomized controlled trial on high-risk coronary artery bypass
graft patients (which included obesity as a high-risk indicator)
found that extended broad-spectrum prophylaxis with a
weight-based dosing regimen signiﬁcantly reduced the rate of
sternal wound infection as compared with a shorter duration of
prophylaxis with cefuroxime alone [26]. A cohort study ofof European Society of Clinical Microbiology and Infectious Diseases. All rights reserved,
TABLE 4. Organisms identiﬁed as causing surgical site infection
Category of surgery Organism Underweight or normal weight, n (%) Overweight or obese, n (%) pa
Abdominal hysterectomy Enterobacteriaceae 1 (25.0) 9 (60.0) —
Staphylococcus aureus (MSSA) 1 (25.0) 4 (26.7) —
CoNS 0 (0.0) 1 (6.7) —
Clostridium difﬁcile 0 (0.0) 1 (6.7) —
Pseudomonas species 0 (0.0) 1 (6.7) —
Anaerobes 0 (0.0) 1 (6.7) —
Enterococci 1 (25.0) 1 (6.7) —
S. aureus (MRSA) 0 (0.0) 1 (6.7) —
Streptococci 1 (25.0) 0 (0.0) —
Coronary artery bypass graft Enterobacteriaceae 35 (42.7) 202 (43.4) 0.898
CoNS 19 (23.2) 136 (29.2) 0.260
Pseudomonas species 21 (25.6) 88 (18.9) 0.162
S. aureus (MSSA) 12 (14.6) 86 (18.5) 0.401
Enterococci 0 (0.0) 30 (6.5) 0.018
Other bacteria 2 (2.4) 15 (3.2) 0.705
Fungi 2 (2.4) 14 (3.0) 0.777
S. aureus (MRSA) 5 (6.1) 13 (2.8) 0.122
Anaerobes 1 (1.2) 8 (1.7) 0.742
Other Gram-positive 2 (2.4) 8 (1.7) 0.654
Non-fermenting Gram-negative rods 0 (0.0) 7 (1.5) 0.263
Streptococci 2 (2.4) 5 (1.1) 0.311
Other Gram-negative 3 (3.7) 1 (0.2) 0.001
Hip and knee replacement S. aureus (MSSA) 28 (30.8) 201 (33.7) 0.585
CoNS 25 (27.5) 163 (27.3) 0.973
Enterobacteriaceae 25 (27.5) 111 (18.6) 0.048
Enterococci 13 (14.3) 68 (11.4) 0.425
S. aureus (MRSA) 11 (12.1) 47 (7.9) 0.178
Other Gram-positive 4 (4.4) 44 (7.4) 0.299
Pseudomonas species 3 (3.3) 43 (7.2) 0.165
Streptococci 8 (8.8) 28 (4.7) 0.102
Other bacteria 0 (0.0) 11 (1.8) 0.192
Anaerobes 4 (4.4) 9 (1.5) 0.059
Non-fermenting Gram-negative rods 2 (2.2) 5 (0.8) 0.228
Fungi 1 (1.1) 3 (0.5) 0.486
Other Gram-negative 0 (0.0) 2 (0.3) 0.580
Large-bowel surgery Enterobacteriaceae 46 (64.8) 143 (61.1) 0.576
Anaerobes 19 (26.8) 55 (23.5) 0.575
Pseudomonas species 7 (9.9) 34 (14.5) 0.312
S. aureus (MSSA) 11 (15.5) 29 (12.4) 0.498
Enterococci 6 (8.5) 27 (11.5) 0.463
Streptococci 7 (9.9) 23 (9.8) 0.994
S. aureus (MRSA) 2 (2.8) 13 (5.6) 0.350
CoNS 2 (2.8) 6 (2.6) 0.907
Other bacteria 0 (0.0) 4 (1.7) 0.267
Other Gram-negative 0 (0.0) 4 (1.7) 0.267
Other Gram-positive 0 (0.0) 4 (1.7) 0.267
Fungi 1 (1.4) 3 (1.3) 0.935
Non-fermenting Gram-negative rods 0 (0.0) 2 (0.9) 0.434
CoNS, coagulase-negative staphylococci; MRSA, methicillin-resistant S. aureus; MSSA, methicillin-susceptible S. aureus.
aχ2 test for independence.
CMI Thelwall et al. Impact of obesity on risk of postoperative infection 1008.e6obese patients undergoing combined hysterectomy and pan-
niculectomy found that extended prophylaxis with ciproﬂoxa-
cin in combination with a single dose of cefalozin reduced the
rates of SSI as compared with a single dose of cefalozin alone
[26]. The reduced tissue penetration of prophylactic antibiotics
in obese surgical patients raises the possibility that obesity may
predispose the patients to infection with resistant strains by
selecting for these through exposure to suboptimal antibiotic
levels [27,28].
Given the wider implications for the selection of antibiotic-
resistant strains of bacteria, strategies to achieve adequate tis-
sue levels at the surgical site should be developed and imple-
mented, ensuring that the choice of agent (i.e. one with good
tissue penetration), dose and duration of therapy are all opti-
mized. Other approaches might include ensuring that skin
preparation is performed stringently, oxygenation is optimizedCrown Copyright © 2015 Clinical Microbiology and Infection published by Elsevier Ltd on behalfand strict glycaemic control is established in diabetic patients
and those with impaired glucose tolerance [29].
Limitations
Owing to the limitations of the routine surveillance data
collection, data on a number of potentially signiﬁcant risk fac-
tors were not collected. Diabetic status is a known risk factor
for SSI, and was not captured by the surveillance. As a result,
diabetic status was not available for this study. The diabetic
status of a patient is likely to lie on the causal pathway between
BMI and the risk of SSI. The effect measures estimated here
therefore estimate the total effect of increased body mass on
the risk of SSI, and the direct effect that is not mediated through
diabetes status is not estimated [30–32]. Prior studies have
failed to demonstrate a clear association between diabetic
status and risk of SSI after adjustment for BMI, possiblyof European Society of Clinical Microbiology and Infectious Diseases. All rights reserved,
CMI, 21, 1008.e1–1008.e8
1008.e7 Clinical Microbiology and Infection, Volume 21 Number 11, November 2015 CMIillustrating the need for capture of data on glycaemic control at
the time of surgery to understand the interplay between these
factors regarding infection risk (Mihalkova et al., Proceedings of
the Public Health England Annual Conference 2014 poster
number 143).
Some differences in the distribution of organisms identiﬁed
from surgical wounds between overweight and obese patients
as compared with normal-weight and underweight patients
were noted. However, the p-values for the differences in dis-
tributions of causative organisms were generally large. Because
multiple comparisons were performed, some of the observed
differences are likely to have occurred by chance. The differ-
ence in distribution of other Gram-negative bacteria among
coronary artery bypass graft patients seems less likely to have
occurred by chance, as indicated by the small p-value for this
association (p 0.001).
BMI data were not recorded for a considerable proportion
of patients undergoing abdominal hysterectomy (62%) or large-
bowel surgery (72%). In these categories, there were
no signiﬁcant differences in the rates of SSI between patients for
whom BMI data were available and patients for whom data
were not available, suggesting an absence of selection
bias. Signiﬁcant differences in the rates of SSI did exist between
patients with and without BMI data for patients undergoing
coronary artery bypass graft, hip replacement, and knee
replacement, suggesting a possible bias in the provision of
height and weight data for patients in these categories. How-
ever, once the hospital identity had been adjusted for, there
was no difference in SSI risk between patients with and without
BMI data. Certain patient characteristics may indicate possible
reasons for the lack of BMI data; patients undergoing surgery
because of trauma were less likely to have BMI data than pa-
tients not undergoing surgery because of trauma.
The results of this study are likely to be generalizable to
other populations. The study had a large sample size drawn
from a large number of centres. The fact that all patients un-
dergoing surgery in the named categories were required to be
followed up mitigates against the risk of selection bias.ConclusionThis study has shown that being overweight or obese increases the
odds of SSI in patients undergoing surgery in England. Continued
surveillance of SSIs of arthroplasty procedures and other cate-
gories of surgery will provide a means of monitoring the impact of
changing obesity rates on postsurgical wound infection.
This effect is likely to continue to increase with the rising
rates of obesity in the general population, and new approaches
are therefore needed to both understand the pathophysiologyCrown Copyright © 2015 Clinical Microbiology and Infection published by Elsevier Ltd on behalf
CMI, 21, 1008.e1–1008.e8of the increase in infection rates in obese surgical patients and
to develop means of reducing rates of infection. The speciﬁc
needs of these patients could be addressed by an increased
focus on weight loss programmes in the time before elective
surgery.
A key approach is to ensure that antimicrobial prophylaxis is
adequate. Current guidelines for the prevention of SSI do not
make speciﬁc recommendations about the prevention of SSI in
obese patients [29]. Guidance on antibiotic prophylaxis is limited
to recommending that prophylactic agents are administered
within 1 h prior to incision and to administer repeat doses in
operations of extended duration. Further research may provide
evidence to reﬁne the current guidelines. Research into
improving other factors such as oxygenation, skin preparation
and glycaemic control in overweight people is also needed.
Continued surveillance of SSI is also essential to provide a
means of monitoring the impact of the changing obesity rate on
postsurgical wound infection, and interventions introduced to
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